Our objective was to explore the restorative effect of
taurine on experimental
nonalcoholic steatohepatitis (NASH). Thirty-six SD rats were randomly divided into three groups, 12 in each group: the normal group was fed standard rat diet; the model group and the treatment group were both fed a high-fat rat diet for 12 weeks, and the rats in the treatment group were simultaneously injected with
taurine subcutaneously for 8 weeks. Hepatic histological change was observed;
TNF-alpha and TGF-beta(1)
protein expression was identified by immunohistochemistry;
mRNA expression of
TNF-alpha, TGF-beta(1),
type I procollagen, and
adiponectin was measured by RT-PCR;
body weight,
weight gain, liver weight, and liver index were measured; and biochemical parameters monitored included serum
transaminases, serum
lipids, fasting plasma
glucose, and hepatic level of oxidative stress. Rats in the model group showed a significant increase in liver weight, liver index, serum
transaminase activities, serum
triglyceride, fasting plasma
glucose, and oxidative stress; the
mRNA expression of
TNF-alpha, TGF-beta(1), and
type I procollagen increased, whereas the expression of
adiponectin decreased significantly, compared with that in the normal group. The typical hepatic lesions of NASH were observed histologically in the model group.
Taurine treatment resulted in a significant decrease in liver weight, liver index, serum
transaminase activities, serum
triglyceride, fasting plasma
glucose, and oxidative stress; the
mRNA expression of
TNF-alpha, TGF-beta(1), and
type I procollagen decreased, but the expression of
adiponectin increased significantly, compared with that in the model group. Histological improvement was observed in the treatment group. In conclusion,
taurine could inhibit lipid peroxidation, improve
lipid and
glucose metabolism, decrease synthesis of
TNF-alpha and TGF-beta(1), promote synthesis of
adiponectin, and have a restorative effect on experimental NASH.